Cargando…

Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy

BACKGROUND: Intensity-modulated radiotherapy (IMRT) is the main salvage treatment for advanced locally recurrent nasopharyngeal carcinoma (NPC); however, survival outcomes vary. We aimed to construct a prognostic-score model to identify patients who could benefit from salvage IMRT. METHODS: This ret...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Y-M, Tian, Y-H, Zeng, L, Liu, S, Guan, Y, Lu, T-X, Han, F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899759/
https://www.ncbi.nlm.nih.gov/pubmed/24335924
http://dx.doi.org/10.1038/bjc.2013.715
_version_ 1782300619970707456
author Tian, Y-M
Tian, Y-H
Zeng, L
Liu, S
Guan, Y
Lu, T-X
Han, F
author_facet Tian, Y-M
Tian, Y-H
Zeng, L
Liu, S
Guan, Y
Lu, T-X
Han, F
author_sort Tian, Y-M
collection PubMed
description BACKGROUND: Intensity-modulated radiotherapy (IMRT) is the main salvage treatment for advanced locally recurrent nasopharyngeal carcinoma (NPC); however, survival outcomes vary. We aimed to construct a prognostic-score model to identify patients who could benefit from salvage IMRT. METHODS: This retrospective study involved 251 patients with locally recurrent NPC. The following parameters were analysed following IMRT: patient performance status, age, gender, late complications, T-stage of recurrence, synchronous nodal recurrence, primary gross tumour volume (GTV-nx), disease-free interval, re-irradiation dose and chemotherapy. The model was based on the hazard ratio coefficients of six significantly negative prognostic factors for survival. RESULTS: Significantly negative prognostic factors included Karnofsky Performance Status ⩽70, age >50 years, late complications, recurrent T(3–4) stage, synchronous nodal recurrence and GTV-nx >30 cm(3). Three subgroups were defined according to model scores: low risk (0–4), intermediate risk (5–8) and high risk (9–15). The 5-year overall survival rates were 64.3%, 32.2% and 7.7%, respectively. The main cause of death was radiation-induced complications. CONCLUSION: The prognostic-score model demonstrated that re-irradiation with IMRT is suitable for low-risk and intermediate-risk patients but may be unsuitable for high-risk patients. Further research into the protection of critical adjacent organs to reduce late complications in these patients is warranted.
format Online
Article
Text
id pubmed-3899759
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-38997592015-01-21 Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy Tian, Y-M Tian, Y-H Zeng, L Liu, S Guan, Y Lu, T-X Han, F Br J Cancer Clinical Study BACKGROUND: Intensity-modulated radiotherapy (IMRT) is the main salvage treatment for advanced locally recurrent nasopharyngeal carcinoma (NPC); however, survival outcomes vary. We aimed to construct a prognostic-score model to identify patients who could benefit from salvage IMRT. METHODS: This retrospective study involved 251 patients with locally recurrent NPC. The following parameters were analysed following IMRT: patient performance status, age, gender, late complications, T-stage of recurrence, synchronous nodal recurrence, primary gross tumour volume (GTV-nx), disease-free interval, re-irradiation dose and chemotherapy. The model was based on the hazard ratio coefficients of six significantly negative prognostic factors for survival. RESULTS: Significantly negative prognostic factors included Karnofsky Performance Status ⩽70, age >50 years, late complications, recurrent T(3–4) stage, synchronous nodal recurrence and GTV-nx >30 cm(3). Three subgroups were defined according to model scores: low risk (0–4), intermediate risk (5–8) and high risk (9–15). The 5-year overall survival rates were 64.3%, 32.2% and 7.7%, respectively. The main cause of death was radiation-induced complications. CONCLUSION: The prognostic-score model demonstrated that re-irradiation with IMRT is suitable for low-risk and intermediate-risk patients but may be unsuitable for high-risk patients. Further research into the protection of critical adjacent organs to reduce late complications in these patients is warranted. Nature Publishing Group 2014-01-21 2013-12-12 /pmc/articles/PMC3899759/ /pubmed/24335924 http://dx.doi.org/10.1038/bjc.2013.715 Text en Copyright © 2014 Cancer Research UK http://creativecommons.org/licenses/by-nc-sa/3.0/ From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
spellingShingle Clinical Study
Tian, Y-M
Tian, Y-H
Zeng, L
Liu, S
Guan, Y
Lu, T-X
Han, F
Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
title Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
title_full Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
title_fullStr Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
title_full_unstemmed Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
title_short Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
title_sort prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3899759/
https://www.ncbi.nlm.nih.gov/pubmed/24335924
http://dx.doi.org/10.1038/bjc.2013.715
work_keys_str_mv AT tianym prognosticmodelforsurvivaloflocalrecurrentnasopharyngealcarcinomawithintensitymodulatedradiotherapy
AT tianyh prognosticmodelforsurvivaloflocalrecurrentnasopharyngealcarcinomawithintensitymodulatedradiotherapy
AT zengl prognosticmodelforsurvivaloflocalrecurrentnasopharyngealcarcinomawithintensitymodulatedradiotherapy
AT lius prognosticmodelforsurvivaloflocalrecurrentnasopharyngealcarcinomawithintensitymodulatedradiotherapy
AT guany prognosticmodelforsurvivaloflocalrecurrentnasopharyngealcarcinomawithintensitymodulatedradiotherapy
AT lutx prognosticmodelforsurvivaloflocalrecurrentnasopharyngealcarcinomawithintensitymodulatedradiotherapy
AT hanf prognosticmodelforsurvivaloflocalrecurrentnasopharyngealcarcinomawithintensitymodulatedradiotherapy